Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously treated metastatic pancreatic cancer.

Metastatic kidney survival rates don’t predict individual outcomes. A number of factors, including overall health, tumor characteristics, and response to treatment, influence prognosis and survival.

Combination with investigational antibody-drug conjugate showed encouraging antitumor acti

Trial met all primary and key secondary endpoints, including progression-free survival and overall survival Company intends to include these data in a future New Drug Application submission to the U.S.

Ferrocene-modified covalent organic frameworks combine sonodynamic therapy with immune activation to suppress primary breast tumors and bone metastasis in mice.

The Technology Alliance’s Discovery Series presents Dr. Cyrus Ghajar from Fred Hutch Cancer Center on the topic of Metastasis in… Read More

Breast cancer can go away for a while and then show up again. It can also spread to different areas of your body when it comes back. Sometimes, breast cancer returns and spreads to the pleura, the lining around your lungs. Doctors call this pleural ...

St. Olaf Lutheran Church hosts free April 23 sessions on cancer metastasis research with Dr. Eric Rahrmann and practical downsizing and moving tips, open to the public.